1 completed, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow Cancer of Cervix: new trials by email Literature Review of Cancer of Cervix trials Research Report on Cancer of Cervix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer DPX-E7 vaccine, Cyclophosphamide - Cancer of Head and Neck, Cancer of Cervix | Phase 1 / Phase 2 | Completed | Dana-Farber Cancer Institute | 11 | 2017-03-30 | 2024-01-11 |
| Ph Ib/BGJ398/Cervix and Other Solid Tumors BGJ398, Carboplatin, Paclitaxel - Cancer of Cervix, Tumors | Phase 1 | Withdrawn | The University of Texas Health Science Center at San Antonio | 2015-01-01 | 2015-02-16 |
Uterine Cervical Neoplasms (2) · Anus Neoplasms (1) · Head and Neck Neoplasms (1) · Neoplasms (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Neoplasms by Site (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Uterine Cervical Diseases (2) · Uterine Diseases (2) · Uterine Neoplasms (2) · Anus Diseases (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1)
Carboplatin (1) · Cyclophosphamide (1) · Paclitaxel (1) · Papillomavirus Vaccines (1) · infigratinib (1)
Dana-Farber Cancer Institute (1) · The University of Texas Health Science Center at San Antonio (1)
United States (1)
Kartik Seghal, MD (1) · Steven Weitman, MD (1)